Bio-Techne (TECH) announced the launch of an expanded menu of human and mouse RNAscope in situ hybridization probes to advance spatial biology ...

Baird analyst Catherine Ramsey Schulte downgraded Bio-Techne (TECH) to Neutral from Outperform with a price target of $68, down from $88. The ...

How Do Unusual Items Influence Profit? Importantly, our data indicates that Bio-Techne's profit was reduced by US$46m, due to unusual items, over the last year. While deductions due to unusual ...

Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of an expanded menu of human and mouse RNAscope™ in situ hybridization probes to advance ...

A generational divide in British politics is playing into Nigel Farage’s hands, as his party Reform UK tops the Techne UK weekly tracker poll for the first time. Overall in the Techne poll ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (TECH) is a leading provider of life sciences solutions dedicated to advancing biomedical research and diagnostics. With a market ...

A generational divide in British politics is playing into Nigel Farage’s hands, as his party Reform UK tops the Techne UK weekly tracker poll for the first time. Overall in the Techne poll, Reform ...

Shares of Bio-Techne Corporation (NASDAQ:TECH) traded higher after the life sciences company topped analysts' expectations with its Q2 FY25 results, indicating a faster topline growth amid early ...

MINNEAPOLIS, Feb. 5, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter ended ...

Shares of Bio-Techne Corp. TECH slipped 2.25% to $68.34 Tuesday, on what proved to be an all-around positive trading session ...